Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Oakridge Global Energy Solutions, Inc. (OGES) Already Sees the Accelerated Future of Electric Vehicles

Speeding to the front of the global energy storage industry is Oakridge Global Energy Solutions, Inc. (OTCQB: OGES). The company specializes in creating cells, energy storage systems, and batteries, all while proudly boasting a ‘Made in the USA’ label. Oakridge builds small and large prismatic stackable lithium cells, which promise 25-30% more energy density than […]

Oakridge Global Energy Solutions, Inc. (OGES) Announces Partnership with Leading International Battery Technology Consultant Firm

Earlier today, Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) announced a new partnership with IST Co. Ltd, a Tokyo, Japan-based firm with broad relationships in the power and stored energy industries. Through this collaboration, the IST team will join the current Oakridge advising team through its previously established subsidiary in Hong Kong. IST is expected […]

Nutra Pharma Corporation (NPHC) Leaning on Revenues Derived from Proven Over-the-Counter Drugs to Fund Development Pipeline

Nutra Pharma Corporation (OTCQB: NPHC), the company behind innovative products such as Nyloxin® and Pet Pain-Away, is set to build on its rich history of pursuing over-the-counter sales as it continues to advance its therapeutic pipeline based on cobra toxin. In an interview with The Life Sciences Report released last October, Rik Deitsch, the company’s […]

 

From Our Blog

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

February 4, 2026

Despite decades of progress in oncology, many cancers remain resistant to treatment, not because therapies are unavailable, but because tumor cells adapt. Immunotherapies and chemotherapies can produce meaningful responses, yet durability and consistency remain challenges, particularly in aggressive or rare cancer subtypes. Increasingly, research is shifting toward approaches that improve how well existing treatments work, […]

Rotate your device 90° to view site.